News Update: March 2021!

March 26th, 2021:  Great Cardiovascular News Announcement!

Discovery of Novel Cardiovascular Risk Markers and Findings by The Cardiovascular Center of Sarasota Resulting in Presentations and Publications at National and International Cardiology Congresses Within the Last 6 Months (Oct 2020 – March 2021)

 

A. Publications in Peer-Review Journals in the Last 6 Months

  1. M. El Shahawy, M.D., Quantification of Epicardial Fat Volume as a Novel Cardiovascular Risk Marker in Asymptomatic Subjects for Early Detection of Cardiovascular Disease. J Health Sci Dev, September 21, 2020.
  2. M. El Shahawy, M.D., Excess Epicardial Fat Volume in Women is a Novel Risk Marker for Microvascular Dysfunction which may be a Contributing Factor in the Atypical Chest Pain Syndrome. Egyptian Journal of Cardiology. 2021.
  3. M. El Shahawy, M.D., Excess Epicardial Fat Volume in Post- Menopausal Women is associated with Increased Cardiovascular Structural and Functional Abnormalities. Accepted for Publication in the Journal of Integrative Cardiology 2021.

 

B. Abstracts Presented at National and International Cardiology Congresses in The Last 6 Months Including the American Heart Association, American College of Cardiology, And European Society of Cardiology.

  1. El Shahawy M., A Stepwise Increase in Epicardial Fat Volume Is Associated with Increased Prevalence of ECG Abnormalities: Time to Assess EFV As A Significant Risk Marker for Possible Arrhythmias. Presented at Annual Congress of the Egyptian Society of Cardiology, Feb 15-18, 2021.
  2. El Shahawy M., Hypertriglyceridemia in Asymptomatic Obese Subjects Without Other Comorbidities Is Associated with Significant Structural and Functional Abnormalities as Compared with Control, 81° Congresso Nazionale SIC - Società Italiana Di Cardiologia – Roma/Virtual, December 17-20, 2020
  3. El Shahawy M., Excess Epicardial Fat Volume as A Novel Risk Factor for CV Structural and Functional Abnormalities, 81° Congresso Nazionale SIC - Società Italiana Di Cardiologia – Roma/Virtual, December 17-20, 2020
  4. M. El Shahawy, MD, “Excess Epicardial Fat Volume Is Associated with Increased Cardiovascular Structural and Functional Abnormalities in Menopausal Women Regardless of Body Weight: The Higher the Epicardial Fat Volume, The Higher The Abnormalities”, Presented At AHA20 Scientific Sessions, November 14-16 2020 In Dallas, Texas.
  5. M. El Shahawy, M.D., “Epicardial Adiposity Is A Gender-Biased Risk Marker for   Cerebrovascular and Coronary Artery Disease in Asymptomatic Obese Subject.” SCCT, July 16-19, 2020 In Seattle, Washington.
  6. El Shahawy M. “Excess Epicardial Fat Volume Regardless of a Low Coronary Artery Calcium Score Is Associated with Higher Cardiovascular Risk: Time to Assess Epicardial Fat Volume in All Cardiac CT Scans.” Accepted for Poster Presentation at The American College of Cardiology Scientific Sessions May 2021
  7. El Shahawy M., “Excess Epicardial Fat Volume in Post- Menopausal Women Is A Novel Cardiovascular Risk Marker.” Submitted to SCCT For Presentation.
  8. El Shahawy M., “A Stepwise Increase in Epicardial Fat Volume Is Associated with Increased Microvascular and Macrovascular Abnormalities.” Submitted to SCCT For Presentation.

 

C. Lectures at National and International Cardiology Congresses Within Last 6 Months

  1. “Scoring Systems Accurately Estimate CVD Risk in Primary Prevention and Should Be Applied to All.” Presented at Annual Congress of the Egyptian Society of Cardiology. February 15th-18th, 2021 In Cairo, Egypt.
  2. “My Strategy of Management in Diabetics in Primary and Secondary CVD Prevention.” Presented at Annual Congress of the Egyptian Society of Cardiology. February 15th-18th, 2021 In Cairo, Egypt.
  3. “Epicardial Fat, A Part of Visceral Obesity or A Specific Risk Factor.” Presented at Annual Congress of the Egyptian Society of Cardiology February 15th-18th, 2021 In Cairo, Egypt.
  4. Chairperson; Joint Session with World Heart Federation. Presented at Annual Congress of the Egyptian Society of Cardiology. February 15th-18th, 2021 In Cairo, Egypt.
  5. Chairperson; Joint Session with International Society Cardiovascular Disease Prevention. Presented at Annual Congress of the Egyptian Society of Cardiology February 15th-18th, 2021 In Cairo, Egypt.
  6. Speaker at the 22ndt Annual Meeting of Preventive Cardiology and Rehabilitation Working Group “CardioPrevent” October 13, 2020 In Cairo, Egypt
  7. “Can We Reduce Microvascular Complications in Diabetes.” Presented At 11th Annual Arab Diabetes Forum October 8th-9th, 2020 Held Virtually.
  8. “Excess Epicardial Fat Volume Is A Novel Cardiovascular Risk Marker Associated with Structural and Functional Abnormalities Novel Data from Our Cardiovascular Center in Sarasota, FL.” To Be Presented At 21st Annual National Sarasota Congress on Cardiovascular Disease Prevention on May 29th, 2021.
  9. “Novel Approach for Primary and Secondary Prevention of Cardiovascular Disease Prevention.” To Be Presented At 21st Annual National Sarasota Congress on Cardiovascular Disease Prevention on May 29th, 2021.
  10. “Obesity with And Without Comorbidities Is A Disease: Novel Data from Our Center in Sarasota, Florida.” To Be Presented At 21st Annual National Sarasota Congress on Cardiovascular Disease Prevention on May 29th, 2021.